Mexico Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Mexico’s Pharmaceuticals and Healthcare Industry
2008-07-25 05:20:00
Mexico Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Mexico’s Pharmaceuticals and Healthcare Industry
DUBLIN, Ireland–(EMWNews)–Research and Markets (http://www.researchandmarkets.com/research/c37020/mexico_pharmaceuti)
has announced the addition of the “Mexico Pharmaceuticals and Healthcare
Report Q3 2008” report to their offering.
Mexico Pharmaceuticals and Healthcare Report provides independent
forecasts and competitive intelligence on Mexico’s pharmaceuticals and
healthcare industry.
Mexico’s pharmaceutical market is expected to
continue its rapid growth over the forecast period to reach a value of
US$28.3bn by 2012, up from an estimated US$14.9bn in 2007. A worsening
chronic disease burden and increased health insurance uptake should
drive volume growth in the pharmaceutical market, while a relatively
free pricing environment when compared with other Latin American markets
should further aid value growth.
The pharmaceutical market is expected to grow 12.9% in local currency in
2008, driven as in the past few years, by moves to more expensive
bioequivalent generics and rising personal wealth. However, the oneoff
gains from stronger bioequivalence regulation driving up the value of
the generics market are expected to wear off over the forecast period,
resulting in market growth to fall back into line with GDP by the end of
the forecast period. The government remains committed to ensuring
similares, or copies without proven bioequivalence, are eradicated from
the market by early 2010.
Key Topics Covered:
Executive Summary
Mexico Pharmaceuticals And Healthcare Industry SWOT
Mexico Political SWOT
Mexico Economic SWOT
Mexico Business Environment SWOT
Pharmaceutical Business Environment Ratings
Limits Of Potential Returns
Risks To Realisation Of Returns
Mexico – Market Summary
Regulatory Regime
Intellectual Property Environment
Pricing And Reimbursement Issues
Other Regulatory Developments
Industry Developments
Healthcare Sector
Pharmaceutical Sector
Generics Sector
Multinational Activity
Research And Development Sector
Industry Forecast Scenario
Overall Market Forecast
Key Growth Factors – Industry
Key Growth Factors – Macroeconomic
Prescription Market Forecast
OTC Market Forecast
Generics Market Forecast
Medical Device Market Forecast
Top Ten Causes Of Death In Mexico, 2002
Pharmaceutical Export/Import Forecasts
Key Risks To BMI’s Forecast Scenario
Company Monitor
Leading Foreign Companies
Pfizer
GlaxoSmithKline (GSK)
Sanofi-Aventis
Eli Lilly
Bristol-Myers Squibb (BMS)
Novartis Farmacéutica
Bayer
Boehringer Ingelheim Promeco
Merck KGaA
Roche
Indigenous Manufacturer Profile
Liomont
Strides Latina (Solara)
BMI Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Weighting
Sources
For more information visit http://www.researchandmarkets.com/research/c37020/mexico_pharmaceuti
Research and Markets 646-607-1907 |
|
Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89
Get Unlimited Organic Website Traffic to your Website
TheNFG.com now offers Organic Lead Generation & Traffic Solutions